ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia. - Schäfer S; Rahimian E; Schmitz-Hübsch L; Shaikh M; Brilloff S; Kufrin V; Küchler S; Fedorova M; Kusebauch N; Ni Z; Helm D; Jeremias I; et al. (Cell reports, 2026)